Key facts
| Price (PPV) | 7,987 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | lévosimendan |
| Class | Cardiac therapy |
| ATC code | C01CX08 |
| Manufacturer | AFRIC-PHAR |
| Presentation | Flacon de 5 ml |
| Hospital price | 7,811 MAD |
| Data collected on | 9/8/2026 |
Indications
Indiqué chez l'adulte dans le traitement à court terme de l’insuffisance cardiaque chronique sévère en décompensation aiguë (ICDA) lorsque le traitement habituel est insuffisant et lorsque l’utilisation d’un agent inotrope est approprié.
Find an open pharmacy
On-call pharmacies near you
About Simdax 2.25 mg / ml
Simdax 2.25 mg / ml belongs to the cardiac therapy therapeutic class. In Morocco, this drug is marketed by AFRIC-PHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Simdax 2.25 mg / ml, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Simdax 2.25 mg / ml
Answers to common questions from Moroccan patients about this drug.